Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Yield and future issues of nucleic acid testing.

W K Roth1, E Seifried

  • 1Institute of Transfusion Medicine and Immunohematology, Red Cross Blood Transfusion Service Hesse, Frankfurt am Main, Germany. wroth@bsdhessen.de

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|August 14, 2001
PubMed
Summary

Nucleic acid testing (NAT) effectively prevents hepatitis C virus (HCV) transmission. Pooling samples with virus enrichment is crucial for hepatitis B virus (HBV) screening and future NAT advancements.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation.

Journal of translational medicine·2022
Same author

Novel method for reduction of virus load in blood plasma by sonication.

European journal of medical research·2020
Same author

Enlargement of the WHO international repository for platelet transfusion-relevant bacteria reference strains.

Vox sanguinis·2017
Same author

Patient Blood Management in Europe: surveys on top indications for red blood cell use and Patient Blood Management organization and activities in seven European university hospitals.

Vox sanguinis·2016
Same author

Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.

Vox sanguinis·2016
Same author

Four amino acid exchanges located in the alpha-2 domain specify the novel HLA-B*50:20 allele.

Tissue antigens·2015

Area of Science:

  • Transfusion Medicine
  • Virology
  • Molecular Diagnostics

Background:

  • Nucleic acid testing (NAT) sensitivity is crucial for blood safety.
  • Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) NAT have shown high efficacy.
  • Hepatitis B virus (HBV) screening via NAT requires optimized approaches.

Purpose of the Study:

  • Evaluate the sensitivity and yield of pooled nucleic acid testing (NAT).
  • Assess NAT strategies for hepatitis B virus (HBV) screening.
  • Identify future directions for NAT automation and cost-efficiency.

Main Methods:

  • Pool-PCR approach for HCV and HIV testing.
  • Sample pooling with virus enrichment for HBV.
  • Analysis of look-back data to assess transmission events.

Related Experiment Videos

Main Results:

  • No HCV transmission observed in Germany post-NAT introduction, indicating high sensitivity.
  • Pooled sample testing with enrichment shows significant yield for HBV.
  • Single donation testing for HBV does not improve yield compared to mini-pool enrichment.

Conclusions:

  • Pooled NAT, especially with enrichment, is effective for blood-borne virus screening.
  • NAT strategies need adaptation for different viruses like HBV.
  • Automation and enrichment are key for future high-throughput, cost-effective NAT systems.